• ERAD-Hijacking Chimeras Degrade Transmembrane Proteins

  2026-08-23

  Song et al. established ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that recruits the ER E3 ligase SYVN1 to remove transmembrane proteins. Their PD-L1 degraders showed subnanomolar activity and stronger tumor suppression than a clinically used PD-L1 antibody, while desonide also enabled degradation of mutant HTT, broadening the approach beyond oncology.

• CUDC-907: Practical PI3K/HDAC Workflow

  2026-08-22

  CUDC-907 (SKU A4097) provides a single research tool for examining coordinated PI3K and HDAC pathway perturbation in cultured cancer models. It is appropriate for controlled in vitro signaling, cell-cycle, and apoptosis studies, but it is not intended for diagnostic, therapeutic, or clinical use.

• High-Throughput MoA Mapping in M. tuberculosis

  2026-08-22

  Santa Maria et al. developed a machine-learning framework that connects phenotypic antibacterial activity with high-throughput biophysical target binding. By integrating 55,000 compounds, 24 historical screens, and 636 bacterial targets, the study recovered known mechanisms and prospectively identified nanomolar inhibitors of Mycobacterium tuberculosis dihydrofolate reductase.

• AZD1480 and the Hidden JAK2/STAT3 Escape Route

  2026-08-21

  A translational framework for using AZD1480 to test tumor-intrinsic STAT3 survival after IDO1 blockade, with compartment-aware assays, mechanistic controls, and guidance for combination research.

• Cinoxacin Workflows for Gram-Negative Research

  2026-08-20

  Cinoxacin supports practical susceptibility, bactericidal, urinary tract infection, and antibiotic resistance studies focused on susceptible Gram-negative organisms. Its flexible agar, broth, disk, and serial-passage workflows make it useful for connecting MIC measurements with phenotypic resistance and assay performance.

• Vasopressin Analogues: Multitasking Peptide Design

  2026-08-20

  The review by Glavaš and colleagues explains how vasopressin analogues convert a short-lived natural hormone into peptides with distinct antidiuretic, vasoconstrictive, and therapeutic profiles. Its central contribution is a structure–activity and application-focused framework linking receptor pharmacology, peptide stability, clinical use, and emerging antiviral hypotheses.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-19

  GS967 enables controlled interrogation of pathological late sodium influx across ventricular myocyte, aging, ischemia, and ex vivo arrhythmia models. This guide translates its potency and electrophysiological selectivity into practical workflows, assay controls, and troubleshooting decisions.

• Procainamide Hydrochloride: Research Workflows

  2026-08-19

  Procainamide Hydrochloride supports complementary cardiac electrophysiology, chemoprotection, inflammatory, and epigenetic assays when its concentration, timing, and compartment-specific effects are measured carefully. This guide translates the key cisplatin hepatoprotection finding into practical workflows while highlighting controls and troubleshooting steps for reproducible research.

• Cerulenin Reveals Leucomycin’s Polyketide Pathway

  2026-08-18

  Takeshima, Kitao, and Omura used cerulenin to show that leucomycin production in Streptomyces kitasatoensis depends on a condensation process analogous to fatty acid biosynthesis. Their combination of inhibitor washout, radiolabeled acetate tracing, and macromolecular synthesis controls provided early experimental support for a polyketide origin of the leucomycin aglycone.

• Adenosine Triphosphate (ATP): Mechanisms & Use

  2026-08-18

  Adenosine Triphosphate (ATP) is a phosphoryl-group donor, metabolic energy carrier, and extracellular signaling molecule. This article connects ATP handling with OGDH regulation, purinergic receptor signaling, and practical use of C6931 in cellular metabolism research.

• Bismuth Subsalicylate: GI Research Workflow

  2026-08-17

  Bismuth Subsalicylate supports gastrointestinal disorder research by combining prostaglandin G/H synthase pathway interrogation with practical phenotyping of cell stress and membrane changes. This workflow addresses its insolubility, fresh-use requirements, annexin V assay integration, and the controls needed to distinguish inflammation pathway modulation from nonspecific cellular injury.

• Azithromycin B1398 for Reliable Assays

  2026-08-17

  A scenario-based guide to using Azithromycin (SKU B1398) in bacterial infection research, resistance profiling, and carefully controlled cell-based assays. It connects mechanism, solvent compatibility, storage, assay interpretation, and vendor-selection criteria to improve experimental reproducibility.

• Palmitic acid: Technical Use and QC Guide

  2026-08-16

  Palmitic acid (SKU N2456) provides a characterized saturated long-chain fatty acid for experiments involving lipid metabolism, inflammation signaling, insulin signaling, and protein palmitoylation. It is intended for controlled laboratory preparation rather than aqueous-only workflows or long-term solution storage, so solvent selection, vehicle controls, and prompt use are essential.

• DDI2–NFE2L1 Signaling Protects Against Ferroptosis

  2026-08-15

  This study identifies DDI2-mediated activation of NFE2L1 as an adaptive proteostasis response to ferroptosis. By combining ubiquitylation proteomics, genetic perturbation, and chemical inhibition, the authors show that disruption of this pathway weakens proteasome recovery and sensitizes cells to oxidative cell death.

• Mestranol and Reversible Lysosomal Stress in Zebrafish

  2026-08-14

  A 2026 Aquatic Toxicology study shows that mestranol can induce a reversible lysosomal storage–like state in zebrafish microglia without increasing microglial abundance or neuronal apoptosis. The work combines live imaging, functional phagocytosis assays, transcriptomics, and TFEC rescue experiments to establish a tractable model of acquired microglial lysosomal dysfunction.

8055 records 1/537 page Next 12345 下5页 Last page